Raphaela Moosbrugger

203P: Immunotherapy improves clinical outcome in KRAS mutated patients with unresectable NSCLC stage III: A subcohort analysis of the Austrian radio-oncological lung cancer study association regristry (ALLSTAR)

Zehentmayr, F. (Erstautor/-in), Klebermass, M. (Co-Autor/-in), Zellinger, B. (Co-Autor/-in), Langer, B. (Co-Autor/-in), Grambozov, B. (Co-Autor/-in), Purevdorj, A. (Co-Autor/-in), Karner, J. (Co-Autor/-in), Gruber, G. (Co-Autor/-in), Stana, M. (Co-Autor/-in), Minasch, D., Kirchhammer, K. (Co-Autor/-in), Steffal, C. (Co-Autor/-in), Stranzl, H. (Co-Autor/-in), Moosbrugger, R. (Co-Autor/-in), Feurstein, P. (Co-Autor/-in), Dieckmann, K. (Co-Autor/-in) & Ruznic, E. (Co-Autor/-in), 2025, in: JOURNAL OF THORACIC ONCOLOGY.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Zehentmayr, F. (Erstautor/-in), Karner, J. (Erstautor/-in), Stana, M. (Co-Autor/-in), Ruznic, E. (Co-Autor/-in), Zellinger, B. (Co-Autor/-in), Klebermass, M., Purevdorj, A., Gruber, G., Minasch, D., Heilmann, M., Moosbrugger, R. (Co-Autor/-in), Roeder, F. (Co-Autor/-in) & Grambozov, B. (Letztautor/-in), 5 Dez. 2025, in: Medical Sciences. 13, 4, 15 S., 305.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Ruznic, E. (Erstautor/-in), Klebermass, M. (Co-Autor/-in), Zellinger, B. (Co-Autor/-in), Langer, B. (Co-Autor/-in), Grambozov, B. (Co-Autor/-in), Purevdorj, A. (Co-Autor/-in), Karner, J. (Co-Autor/-in), Gruber, G. (Co-Autor/-in), Stana, M. (Co-Autor/-in), Minasch, D. (Co-Autor/-in), Kirchhammer, K., Steffal, C. (Co-Autor/-in), Stranzl, H. (Co-Autor/-in), Moosbrugger, R. (Co-Autor/-in), Feurstein, P. (Co-Autor/-in), Dieckmann, K. (Co-Autor/-in), Zehentmayr, F. (Letztautor/-in) & ALLSTAR Group, 1 Feb. 2025, in: Journal of Clinical Medicine. 14, 3, 16 S., 945.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Hochreiter, A. (Erstautor/-in), Stana, M. (Erstautor/-in), Klebermass, M., Ruznic, E. (Co-Autor/-in), Grambozov, B. (Co-Autor/-in), Karner, J. (Co-Autor/-in), Heilmann, M., Minasch, D., Purevdorj, A., Gruber, G., Moosbrugger, R. (Co-Autor/-in), Roder, F. (Co-Autor/-in) & Zehentmayr, F. (Letztautor/-in), 15 Dez. 2025, in: Journal of Clinical Medicine. 14, 24, 20 S., 8876.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung